Cases & Deals

Idenix challenges Gilead's patent rights to methods of treating HCV with Sovaldi® (sofosbuvir)

Client(s) Idenix Pharmaceuticals LLC

Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in a patent interference against Gilead. Subject matter is methods for treating a host infected with hepatitis C virus by administering a nucleoside analog or prodrug.

Storer v. Clark, Interference 105,981 (USPTO Patent Trial and Appeal Board)